Swine Flu may be Lab Contamination, New Book unveils severe Biosafety lacks
According to Australian virologist Adrian Gibbs, the H1N1/A-Virus could be the product of a vaccine-plant or a lab. Gibbs, who considered this to be a possible explanation of the New Influenza, now published his findings in Virology Journal. By this he renewed “discussion about the origins of the pandemic
virus”, as ProMED is explaining. As ProMED also explains, “the new pandemic (H1N1) 2009 virus, which was discovered in Mexico and the U.S. in April [2009], may be the product of 3 strains from 3 continents that swapped genes in a lab or a
vaccine-manufacturing plant”. Gibbss is getting support from the Life Sciences Magazine LifeGen.de, which published a few days ago a book about massive security lacks in the virological industry. The book named “Swine Flu as a Millenium Fake” is written in German but contains important pages also in English.
Some passages: “Highly pathogenic virus-samples are sent around the globe by many pharmaceutical and biotech companies. They work with lethal viruses, and many of these labs have subcontractors which can't secure the deadly stuff in an appropriate way. Worst of all, security lacks could initiate a new bioterrorist threat coming from inside western countries – not because of Baxter, but because it became evident that samples can be out of routine control even if belonging to pharmaceutical giants working very professional – usually”.
Swine flu as a millennium Fake: Chronicle of a planned disease
The spread of Swine Flu (New Influenza) has ignited a unique, global process: Never before have been vaccines marketed so fast and with so few long-term clinical data on possible risks and side effects. Only a few months after virologists identified the virus H1N1 / A, the Geneva-based World Health Organization (WHO) declared the pandemic status of the disease. This decision seems more than unusual for two reasons. Firstly, the emergence of novel strains of a virus is not new. On the other hand the burgeoning swine flu in Mexico proved to be a relatively harmless version of a new influenza virus. Now a new book published by LifeGen.de is looking at one possible question: Swine flu as a millennium Fake. The book which is written in German has been edited by bestselling science writers and LifeGen.de Editors in Chief Marita Vollborn and Vlad Georgescu and will appear shortly also in an English translation.
However, the activism of the WHO had far-reaching consequences. Almost instantly precisely those antiviral agents moved into the focus of public health authorities, which had proved to be increasingly ineffective against conventional flu viruses before Swine flu started. The WHO helped - intentionally or not- pharmaceutical manufacturers to an unexpected comeback of their antiviral old guard.
Für den Volltext-Zugang zu unseren Inhalten bitte mit Ihrem Usernamen/Passwort hier einloggen, wenn Sie bereits zahlender Abonnent von LifeGen.de sind. Passwort vergessen?
Falls Sie kein zahlender Abonnent sind, dann können Sie unseren ClickandBuy Service nutzen.
Bestellen Sie unseren KOSTENLOSEN Newsletter mit dem Nachrichten-Überblick
According to Australian virologist Adrian Gibbs, the H1N1/A-Virus could be the product of a vaccine-plant or a lab. Gibbs, who considered this to be a possible explanation of the New Influenza, now published his findings in Virology Journal. By this he renewed “discussion about the origins of the pandemic
virus”, as ProMED is explaining. As ProMED also explains, “the new pandemic (H1N1) 2009 virus, which was discovered in Mexico and the U.S. in April [2009], may be the product of 3 strains from 3 continents that swapped genes in a lab or a
vaccine-manufacturing plant”. Gibbss is getting support from the Life Sciences Magazine LifeGen.de, which published a few days ago a book about massive security lacks in the virological industry. The book named “Swine Flu as a Millenium Fake” is written in German but contains important pages also in English. 
Some passages: “Highly pathogenic virus-samples are sent around the globe by many pharmaceutical and biotech companies. They work with lethal viruses, and many of these labs have subcontractors which can't secure the deadly stuff in an appropriate way. Worst of all, security lacks could initiate a new bioterrorist threat coming from inside western countries – not because of Baxter, but because it became evident that samples can be out of routine control even if belonging to pharmaceutical giants working very professional – usually”.
